Cyanidin is an agonistic ligand for peroxisome proliferator-activated receptor-alpha reducing hepatic lipid

Biochim Biophys Acta. 2013 Apr;1831(4):698-708. doi: 10.1016/j.bbalip.2012.11.012. Epub 2012 Dec 8.

Abstract

To investigate the underlying mechanism of targets of cyanidin, a flavonoid, which exhibits potent anti-atherogenic activities in vitro and in vivo, a natural chemical library that identified potent agonistic activity between cyanidin and peroxisome proliferator-activated receptors (PPAR) was performed. Cyanidin induced transactivation activity in all three PPAR subtypes in a reporter gene assay and time-resolved fluorescence energy transfer analyses. Cyanidin also bound directly to all three subtypes, as assessed by surface plasmon resonance experiments, and showed the greatest affinity to PPARα. These effects were confirmed by measuring the expression of unique genes of each PPAR subtype. Cyanidin significantly reduced cellular lipid concentrations in lipid-loaded steatotic hepatocytes. In addition, transcriptome profiling in lipid-loaded primary hepatocytes revealed that the net effects of stimulation with cyanidin on lipid metabolic pathways were similar to those elicited by hypolipidemic drugs. Cyanidin likely acts as a physiological PPARα agonist and potentially for PPARβ/δ and γ, and reduces hepatic lipid concentrations by rewiring the expression of genes involved in lipid metabolic pathways.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anthocyanins / pharmacology*
  • CHO Cells
  • Cells, Cultured
  • Cricetinae
  • Hep G2 Cells
  • Hepatocytes / drug effects*
  • Hepatocytes / metabolism*
  • Humans
  • Lipid Metabolism / drug effects
  • PPAR alpha / agonists*
  • PPAR gamma / agonists
  • PPAR-beta / agonists

Substances

  • Anthocyanins
  • PPAR alpha
  • PPAR gamma
  • PPAR-beta
  • cyanidin